PotentandselectiveGPBAagonist(EC50=0.72nMforhTGR5).SelectiveforTGR5overFXR(farnesoidXreceptor).IncreasesplasmaGLP-1levelsandreducesbloodglucoseinmice.Orallyavailable.
TC-G1005isalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
M.Wt | 399.48 |
Formula | C25H25N3O2 |
Storage | Storeat-20°C |
Purity | ≥98%(HPLC) |
CASNumber | 1415407-60-1 |
PubChemID | 71450251 |
InChIKey | JQULIQJSYPZQMA-UHFFFAOYSA-N |
Smiles | CC1=CC(OC2=CC=NC=C2C(N3C(C=CC=C4)=C4N(C5CC5)CC3)=O)=C(C)C=C1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 39.95 | 100 | |
ethanol | 39.95 | 100 |
Thefollowingdataisbasedontheproductmolecularweight399.48.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 2.5mL | 12.52mL | 25.03mL |
5mM | 0.5mL | 2.5mL | 5.01mL |
10mM | 0.25mL | 1.25mL | 2.5mL |
50mM | 0.05mL | 0.25mL | 0.5mL |